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ABSTRACT 
Objective: To investigate the differences in main characteristics, reporting and methodological quality 
between prospectively registered and non-registered systematic reviews. 
Methods: PubMed was searched to identify systematic reviews of randomized controlled trials 
published in 2015 in English. After title and abstract screening, potentially relevant reviews were 
divided into three groups: registered non-Cochrane reviews, Cochrane reviews, and non-registered 
reviews. For each group, random number tables were generated in Microsoft Excel, and the first 50 
eligible studies from each group were randomly selected. Data of interest from systematic reviews were 
extracted. Regression analyses were conducted to explore the association between total R-AMSTAR or 
PRISMA scores and the selected characteristics of systematic reviews.  
Results: The conducting and reporting of literature search in registered reviews were superior to 
non-registered reviews. Differences in nine of the 11 R-AMSTAR items were statistically significant 
between registered and non-registered reviews. The total R-AMSTAR score of registered reviews was 
higher than non-registered reviews (MD=4.82, 95%CI: 3.70, 5.94). Sensitivity analysis by excluding 
the registration related item presented similar result (MD=4.34, 95%CI: 3.28, 5.40). Total PRISMA 
scores of registered reviews were significantly higher than non-registered reviews (all reviews: 
MD=1.47, 95%CI: 0.64-2.30; non-Cochrane reviews: MD=1.49, 95%CI: 0.56-2.42). However, the 
difference in the total PRISMA score was no longer statistically significant after excluding the item 
related to registration (item 5). Regression analyses showed similar results. 
Conclusions: Prospective registration may at least indirectly improve the overall methodological 
quality of systematic reviews, although its impact on the overall reporting quality was not significant.  
 
Keywords: Prospective registration; Quality; Systematic reviews; Meta-epidemiological study 
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What is new? 
• Key finding: Prospective registration could indirectly improve the overall methodological quality 
of systematic reviews. 
• What this adds to what is known: We conducted firstly a meta-epidemiological study to 
investigate the impact of prospective registration on reporting and methodological quality of 
systematic reviews. It was significantly meaningful that prospectively registered systematic 
reviews showed higher methodological quality than non-registered systematic reviews. 
• What is the implication, what should change now: Many of published systematic reviews were 
poorly conducted and reported. Strategies improving the quality of systematic reviews should be 
explored to reduce this avoidable waste in research. A protocol written in advance of a systematic 
review may reduce bias in the conduct and reporting process, and should be performed in further 
training of authors of systematic reviews.
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INTRODUCTION 
Well-conducted systematic reviews and meta-analyses of randomized controlled trials are accepted as 
the best-quality evidence to inform policy and practice [1,2]. It was estimated that more than 8,000 
systematic reviews were indexed in MEDLINE annually, corresponding to a 3-fold increase over the 
last decade [3]. However, many of published systematic reviews were poorly conducted and reported 
[3], and need to be improved in terms of the reporting and methodological quality. 
A key feature of a high-quality systematic review is to pre-specify the main objectives, literature search 
strategy, inclusion/exclusion criteria, methods for data extraction and quality assessment, and planned 
analyses for the review in a protocol [4]. A protocol written in advance of a systematic review may 
reduce bias in the conduct and reporting process [4]. In order to enhance the transparency of review 
objectives and methods and avoid outcome reporting bias, the Cochrane Collaboration requests that a 
protocol should be prepared before conducting the Cochrane systematic review [5]. International 
Journal of Obstetrics and Gynaecology was the first journal to set up a system for the formal 
registration of protocols for systematic reviews of test accuracy studies in 2005 [6]. With the increasing 
momentum of support for prospective registration of protocols for systematic reviews, an International 
Prospective Register of Systematic Reviews (PROSPERO) was established in 2011 and is the only 
open-access online facility to prospectively register non-Cochrane systematic reviews [7]. After that, 
many organisations and networks (e.g., NIHR, WHO, Cochrane and Campbell Collaborations), and 
publishers (e.g., PLoS journals, BMJ, BioMed Central) have expressed their support for the prospective 
registration of systematic review protocols [7]. Currently, there are over 15,000 systematic reviews 
registered on PROSPERO, and more than 1,500 records are marked as completed or published. 
However, there is a lack of empirical evidence about whether prospective registration of protocols 
improves the overall reporting and methodological quality of systematic reviews. According to our 
knowledge, there are no previous published studies that systematically compared quality of 
non-Cochrane systematic reviews of healthcare interventions that were prospective registered and those 
that were not registered. 
The primary objective of this study was to investigate differences in the main characteristics, reporting 
and methodological quality between registered (including Cochrane reviews) and non-registered 
systematic reviews. Secondary objectives were to compare the differences between registered 
non-Cochrane systematic reviews and non-registered systematic reviews, and explore the association 
between overall reporting and methodological quality and selected characteristics of systematic 
reviews. 
 
METHODS 
Eligibility criteria 
We included systematic reviews with or without meta-analysis that met the following criteria: (1) 
explicitly stated methods to identify studies, explicitly stated methods of study selection, and explicitly 
described the methods of evidence synthesis; (2) were fully published in English language in 2015, and 
(3) included only randomised controlled trials (RCTs) to evaluate clinical effects of healthcare 
interventions. 
We excluded systematic reviews that included both RCTs and non-randomised studies, didn’t focus on 
healthcare interventions (e.g., diagnostic, etiology, and prognosis), methodology reviews, scoping or 
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rapid reviews, umbrella overviews, review protocols, abstracts/proceedings, and letters to editors. 
Identification and selection of systematic reviews 
PubMed was searched on June 11th 2016 to identify relevant systematic reviews and meta-analyses. 
The search strategy was “(randomised[Title/Abstract] OR randomized[Title/Abstract] OR 
RCTs[Title/Abstract]) AND (Meta-Analysis[ptyp] OR systematic[sb])”. The search date was limited 
from 1st January 2015 to 31st December 2015. The search strategy was developed by one reviewer (LG), 
with support from two senior reviewers (J-HT and K-HY) who both have more than 10 years’ 
experience as information specialists.  
Literature search records were imported into ENDNOTE X6 literature management software. Two 
independent reviewers (LG, JL) examined the title and abstract of retrieved records to identify possibly 
relevant reviews, and independently examined full-text of potentially relevant reviews according to the 
eligibility criteria. Conflicts were resolved by a third reviewer (J-HT, or K-HY). 
Study design 
This is a comparative meta-epidemiological study to investigate whether prospective registration is 
associated with methodological and reporting quality of systematic reviews. Registration status of 
non-Cochrane systematic reviews was initially decided according to whether the registration 
information was provided in abstract, or whether a protocol was mentioned in abstract. After title and 
abstract selection, potentially relevant reviews were divided into three groups: registered non-Cochrane 
systematic reviews, Cochrane systematic reviews, and non-registered systematic reviews. Registered 
systematic reviews were those that had a protocol in advanced of the review no matter whether a 
registration number was available or not. Because the number of registered non-Cochrane systematic 
reviews is predictably small for one year, registered systematic reviews consist of registered 
non-Cochrane systematic reviews and Cochrane reviews. For each group, the random number tables 
were generated in Microsoft Excel (Microsoft Corp, Redmond, WA, www.microsoft.com), and the first 
50 eligible studies from each group were selected. If a selected systematic review was not eligible after 
reading the full-text, a successive record was used to replace it until the total number of included 
systematic reviews was 50 for each of the three groups. Random selection of systematic reviews was 
carried out by one reviewer (LG).  
Data extraction and management 
A draft data extraction form was developed using Microsoft Excel 2013 (Microsoft Corp, Redmond, 
WA, www.microsoft.com). Reviewers involved in data extraction piloted the form on a random sample 
of five included systematic reviews to ensure consistency in interpretation of data items. The form was 
revised when considered necessary. Then, one of three reviewers (LG, Y-NL, or J-XP) extracted data 
from the included systematic reviews, and another reviewer (J-H T or K-H Y) checked the extracted 
data. Any conflicts were resolved by discussion. 
Data of interest from systematic reviews included general review characteristics, reporting of literature 
search, methodological quality based on Revised Assessment of Multiple Systematic Reviews 
(R-AMSTAR) checklist [8], and reporting quality based on Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) statement [10].  
General review characteristics 
The following general review characteristics were collected: first author’s name, year of publication, 
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country of the corresponding author, journal name, funding source, number of authors, number of 
included randomised controlled trials, total number of patients included, original or updated systematic 
reviews, protocol register, categories of disease, and type of interventions. The details of items 
extracted are presented in Appendix 1. 
Reporting of literature search methods 
We obtained the following information on literature search methods: the number and name of 
electronic bibliographic databases searched, year of coverage, search terms reported, the search 
strategy provided, the number and name of other sources searched (e.g., reference lists checking, 
clinical trial registration platform, conference abstracts or web sites, Google engine). 
Methodological quality assessment 
We assessed the methodological quality of included systematic reviews using the R-AMSTAR 
checklist [8], which was the revised version of the AMSTAR [9]. Compared to the original AMSTAR, 
the R-AMSTAR could be used more conveniently to quantify the methodological quality of published 
systematic reviews [8]. Each of the R-AMSTAR checklist items can be scored from 1 to 4, according to 
whether the assessed criterion was explicitly met in the systematic review: The score is ‘1’ if zero or 
one criteria was met, and ‘4’ if all criteria were met. A greater R-AMSTAR score indicates the higher 
methodological quality of a systematic review. The detailed R-AMSTAR checklist and assessment 
criteria are shown in Appendix 2.  
Reporting quality assessment 
The reporting quality of included systematic reviews was assessed according to the Preferred Reporting 
Items for Systematic Reviews and Meta-analyses (PRISMA) [10], which is a checklist with twenty 
seven items. To indicate the degree of compliance, each checklist item was assigned one of the 
following four responses: ‘Yes’ for total compliance; ‘Partial’ for partial compliance; ‘No’ for 
noncompliance; and ‘Cannot answer’ for limited information. The total score of reporting quality was 
obtained by summing ‘1’ point for each ‘yes’, ‘0.5’ for each ‘partial’, and ‘0’ point for any other 
responses (‘No’, and ‘Cannot answer’). 
Data analysis 
We compared the general review characteristics, reporting of literature search methods, and the 
methodological and reporting quality between registered (including Cochrane reviews) and 
non-registered systematic reviews, and between non-Cochrane registered systematic reviews and 
non-registered reviews. We used frequency and percentage for categorical variables (including data on 
individual items of R-AMSTAR and PRISMA), and median and interquartile range (IQR) for 
continuous variables. Chi-squared test was used to statistically test differences in categorical items, and 
nonparametric statistical approach (two sample Wilcoxon rank-sum test) or student t test to test 
differences in continuous items. Fisher’s exact test was used if a contingency table contained a cell 
with 5 or fewer events.  
For each of the 27 PRISMA items, we summarized the frequency of ‘Yes’ response to all included 
systematic reviews, and calculated odds ratio (OR) with 95% confident intervals (95% CI) to compare 
the compliance between registered and non-registered systematic reviews. The OR value represents the 
relative frequency of ‘Yes’ responses in group one versus that in group two. For each item, OR>1 
indicates that the odds of compliance in the group one is greater than in the group two. For each of the 
11 R-AMSTAR item, we calculated mean score and standard deviation (SD). The mean difference (MD) 
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and 95% CI were calculated for each item to compare the overall methodological quality between 
comparison groups. The MD value represents the difference in the mean score between group one and 
group two. MD>0 indicates that the group one had a mean score higher than the group two.  
Either bivariate or multiple variable linear regression analyses were conducted to explore the 
association between total R-AMSTAR scores or PRISMA scores (as the dependent variable) and the 
selected characteristics of systematic reviews. Relevant analyses were conducted by using data from all 
included systematic reviews and by excluding Cochrane reviews. Statistical significance was defined as 
two sided P≤0.05.  
In addition, we performed sensitivity analyses to inspect the robustness of results by excluding the item 
related to registration (item 1 for R-AMSTAR, item 5 for PRISMA). We used JMP version 13.0 for 
statistical analyses. 
 
RESULTS 
Search results 
Initial literature search retrieved 8,131 citations. Based on titles and abstracts, 3,044 citations were 
excluded. Of them, 854 were published in 2016, 1,052 were not systematic reviews, and 1,138 included 
non-randomized studies. 5,087 citations were divided into three groups, and 50 samples were randomly 
selected for each group (Figure 1). The citations of included systematic reviews can be found in 
Appendix 3.  
General characteristics of included systematic reviews 
The general characteristics of the included reviews are shown in Table 1. The included systematic 
reviews were conducted in 28 different countries, mostly in the UK (22.0%), China (19.3%), the USA 
(12.0%), and Australia (9.3%) (Figure 2). The included systematic reviews were concerning a wide 
range of disease categories, including diseases of the musculoskeletal system and connective tissue 
(11.3%), mental and behavioral disorders (10.7%), and diseases of the circulatory system (10.0%) 
(Figure 3). 
The registered non-Cochrane reviews were registered in PROSPERO (88%), and/or published the 
review protocols in peer-reviewed journals (16%). Of the registered non-Cochrane systematic reviews, 
58% were published in specialty journals. Most (94%) were indexed in Science Citation Index (SCI) 
database, and the median impact factor was 3.057 (IQR: 2.562-5.722). These reviews included a 
median of 11 RCTs and a median number of 1,549 patients. 56% of the registered non-Cochrane 
reviews reported the sources of funding, 96% were sponsored by non-profile organizations, and 72% 
investigated a non-pharmacological intervention. The Cochrane reviews included a median of 8 RCTs 
involving 1,265 patients. 82% of the Cochrane reviews were sponsored by non-profile organizations, 
and 64% investigated a non-pharmacological intervention. Compared with the registered reviews, the 
non-registered systematic reviews were less likely to be indexed in SCI (88% vs.97%, P=0.04), with a 
lower median impact factor (2.448 vs. 6.103, P<0.001), and less likely with funding from non-profit 
sponsor (26% vs. 69%, P<0.001).  
Reporting of literature search methods 
All included reviews provided information on literature search (Appendix 4). The median number of 
electronic bibliographic databases searched in the registered reviews was greater than in the 
non-registered reviews (5 vs. 4, P<0.001). The year of coverage was reported in 64% of the registered 
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reviews, compared to 44% of the non-registered reviews (P=0.02). More registered reviews reported 
full search strategies compared with the non-registered reviews (82% vs. 34%, P<0.001). 
PubMed/MEDLINE (95% vs. 98%, P=0.53), EMBASE (87% vs. 66%, P=0.003), and CENTRAL 
(51% vs. 18%, P<0.001) were the common databases searched. Compared to non-registered reviews, 
more registered reviews searched clinical trial registries (P=0.03), reference lists (P=0.03), ongoing 
trials (P<0.001) and abstracts/proceeding (P=0.003).  
Methodological quality of included systematic reviews 
The R-AMSTAR checklist consists of 11 items involving 50 assessment points, and details of 
R-AMSTAR scores are shown in Appendix 5. Responses to 58% of the assessment points were 
statistically significant between registered and non-registered reviews. For 9 of the 11 R-AMSTAR 
items, the differences in the score were statistically significant between registered and non-registered 
systematic reviews (Figure 4, Appendix 6-8). The total R-AMSTAR score of the registered reviews was 
higher than the non-registered reviews (MD=4.82, 95%CI: 3.70, 5.94). Sensitivity analysis by 
excluding item related to registration presented similar result (MD=4.34, 95%CI: 3.28, 5.40) 
(Appendix 6). After excluding Cochrane reviews, 5 of the 11 R-AMSTAR items had significant 
differences between the registered non-Cochrane reviews and non-registered reviews. In sensitivity 
analysis, total R-AMSTAR scores of the registered non-Cochrane reviews remained higher than the 
non-registered reviews (Appendix 7). However, these scores were relatively low compared with 
Cochrane reviews (total scores: MD=-3.92, 95%CI: -4.94, -2.90; sensitivity analysis: MD=-3.44, 
95%CI: -4.42, -2.46) (Appendix 8). 
Reporting quality of included systematic reviews 
Figure 5 shows reporting quality of systematic reviews, measured with total compliance for each of the 
27 PRISMA items. Except for item related to registration (item 5), the total compliance rates of item 2, 
item 4, item 8, item 18, and item 27 were significantly higher in the registered reviews than in the 
non-registered reviews (Figure 5, Appendix 9). After excluding Cochrane reviews, differences in item 4 
and item 18 were no longer statistically significant, while differences in item 16 and item 23 became 
statistically significant (Figure 5, Appendix 10). When compared to Cochrane reviews, the total 
compliance rates of 6 items were significantly lower in the registered non-Cochrane reviews (Figure 5, 
Appendix 11). Figure 6 shows that the total PRISMA scores of the registered reviews (no matter 
whether Cochrane reviews were included) were significantly higher than the non-registered reviews. 
However, there were no statistically significant differences between them when item related to 
registration (item 5) was excluded. 
Results of regression analyses 
Using data from all systematic reviews, the total R-AMSTAR scores were statistically significantly 
associated with registration status, impact factors, and funding sources in either bivariate or multiple 
variable linear regression analyses (Appendix 12-1). The differences in sensitivity analyses and 
analyses after excluding Cochrane reviews remained significant (Appendix 12-1, 2). Total PRISMA 
scores were significantly associated with registration status and funding sources when all systematic 
reviews were included in either bivariate or multiple variable linear regression analyses (Appendix 
12-3). After excluding Cochrane reviews, the differences remained significant (Appendix 12-4). 
However, the differences of registration status were no longer significant in sensitivity analyses 
(Appendix 12-3, 4). 
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DISCUSSION 
Summary of finding 
Currently, most of methodological studies focused on the transparency and selective reporting bias of 
outcomes of systematic reviews [11-13]. A registry of protocols of systematic reviews might reduce 
publication bias, enhance transparency and avoid duplication of effort [14]. Present study firstly 
focused on the association between prospective registration and overall reporting and methodological 
quality of systematic reviews. Results indicated that prospective registration could improve the overall 
methodological quality of systematic reviews, but only slightly improved overall reporting quality. 
Sensitivity analyses, analyses after excluding Cochrane reviews, and regression analyses showed 
similar results. 
Compared with non-registered reviews, registered reviews (either Cochrane or non-Cochrane reviews) 
were more likely to be published in SCI journals with higher impact factors and to be financially 
sponsored. Most of the included registered non-Cochrane reviews were registered in PROSPERO, 
which was the only open-access online facility to prospectively register non-Cochrane systematic 
reviews. Some peer-reviewed journals, like BMJ Open and Systematic Review, are publishing protocols 
of planned or ongoing systematic reviews. However, only 16% registered non-Cochrane reviews 
published corresponding protocols in peer-reviewed journals. What’s more, there were no statistical 
differences in interventions concerned between registered and non-registered reviews. For literature 
search reporting, the conduct and reporting of registered reviews were superior to non-registered 
reviews. Compared to non-registered reviews, registered reviews searched more electronic 
bibliographic databases, and search terms, search strategies, and clinical trial registers searched were 
more comprehensive. Furthermore, it was more common for registered reviews to search EMBASE, 
CENTRAL, CINAHL, and LILACS. An additional phenomenon was that Chinese databases were 
searched rarely in all included systematic reviews. To our knowledge, there were no relevant studies to 
investigate the impact of Chinese clinical trials inclusion on estimates of intervention effects and 
diagnostic accuracy in performing systematic reviews. However, previous study indicated that Chinese 
biomedical databases should be searched when performing systematic reviews [15]. Actually, Cochrane 
Handbook also recommended the search of at least one Chinese databases like Chinese biomedical 
literature database [5], although this recommendation has not been widely implemented in Cochrane 
reviewers [15]. 
For methodological quality based on R-AMSTAR scores, registered reviews (including Cochrane 
reviews or not) were superior to non-registered reviews, especially regarding to the duplication of study 
selection and data extraction, rigor of literature search, consideration of publication status, and 
reporting of conflict of interest. Our study focused on the association between registration and 
reporting and methodological quality of systematic reviews, therefore, we performed sensitivity 
analyses by excluding item related to registration. Results were not materially different before and after 
excluding the registration-related item from the R-AMSTAR items. For reporting quality, there were no 
statistical differences in most of the PRISMA items between registered and non-registered reviews. The 
total PRISMA score of registered reviews was higher than non-registered reviews, although the 
difference was no longer statistically significant after excluding item 5 (protocol and registration) or 
Cochrane reviews. The direct comparison of methodological and reporting quality scores in systematic 
reviews from different groups may be confounded by certain review characteristics. Therefore, we 
conducted bivariate or multiple variable linear regression analyses to adjust for multiple review 
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characteristics. The overall differences in methodological quality between registered and non-registered 
systematic reviews remained statistically significant after adjusting for multiple review characteristics. 
Exploring strategies improving the quality of systematic reviews 
Reporting and methodological quality of published systematic reviews have been examined in 
numerous previous studies. A search of PubMed on October 10th 2016, using a high specificity search 
strategy ((("systematic review*"[Title] OR "meta analys*"[Title]))) AND (((quality[Title] OR 
compliance[Title] OR methodological[Title] OR reporting[Title]))) [16], identified 1,780 studies on the 
assessment of quality of systematic reviews. Consistency with a recent study published in PLoS 
Medicine [3], previous studies usually indicated that the reporting and methodological quality of 
published systematic reviews needed to be further improved with respect to some quality items. 
Strategies improving the quality of systematic reviews should be explored to reduce this avoidable 
waste in research. The subgroup analyses of our previous study focused on systematic reviews of 
diagnostic tests published by Chinese authors showed that compliance rates of some PRISMA items 
were improved for systematic reviews sponsored with funding [17]. Another study focused on 
systematic reviews published in “evidence-based” Chinese journals showed that factors associated with 
higher reporting quality of systematic reviews included papers with funding and papers conducted 
collaboratively by hospital staff and university researchers [18].  
Present study focused on the impact of prospective registration on overall reporting and methodological 
quality of systematic reviews, especially regarding to study selection, data extraction, literature search, 
consideration of publication status, and reporting of conflict of interest. Results indicated that 
systematic reviews registered in advance showed higher methodological quality. However, prospective 
registration in itself would not improve the quality of systematic reviews. We had to consider more 
direct factors such as researchers’ conceptual knowledge on systematic reviews. Researchers of 
registered systematic reviews might master more skills in conducting high quality systematic reviews. 
Prospectively registration of systematic reviews requires the development of a review protocol, and 
researchers to be more familiar with the requirements by PRISMA and PROSPERO. Therefore, 
prospective registration may be at least an indirect strategy to improve the methodological quality of 
systematic reviews. 
Strengths and limitations 
Prospective registration of protocols in advance was a key feature of a high-quality systematic review 
[4]. The present study is the first meta-epidemiological study to investigate the impact of prospective 
registration on reporting and methodological quality of systematic reviews. It was significantly 
meaningful to find that prospective registration improves the methodological quality of systematic 
reviews. Cochrane reviews have higher reporting and methodological quality than systematic reviews 
published in journals [3,19]. Therefore, we compared the differences of general characteristics, 
literature search, reporting and methodological quality before and after excluding Cochrane reviews. 
Because we are concerned about the impact of registration, we performed sensitivity analyses by 
excluding registration or protocol related items from the R-AMSTAR and PRISMA checklist. 
There were some limitations in our study. Firstly, registration status of non-Cochrane systematic 
reviews was initially decided according to whether the registration information was reported in abstract, 
or whether a protocol was mentioned in abstract. There were non-Cochrane systematic reviews 
prospectively registered, but did not mention the protocol or registration in abstract. This may introduce 
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selection bias in the process of identifying registered systematic reviews, although the impact of such 
potential bias is unlikely to be considerable. Secondly, we searched only PubMed database with 
high-specificity search terms to identify systematic reviews published in 2015. However, there are no 
reasons to suspect that the results will be much different if more databases were searched to identify 
published systematic reviews. In addition, we included only systematic reviews of RCTs published in 
English, the finding may not be generalizable to systematic reviews of other types (e.g., observational 
studies, diagnostic tests) and systematic reviews published in other languages. Because we only 
included systematic reviews published in 2015, it was not possible to observe the association of 
prospective registration and quality over time. Thirdly, there were still some argument for 
methodological quality assessment tools of systematic review. Previous study found original AMSTAR 
had better measurement properties than R-AMSTAR [20]. However, original AMSTAR items also have 
some drawbacks [21]. The R-AMSTAR overcome some drawbacks of the original AMSTAR and could 
more conveniently quantify the quality of systematic reviews. Fourthly, the assessment of 
methodological quality of systematic reviews was based on what was reported by authors, and the 
actual conduct might be different. Fifthly, we included funding sources as an independent variable in 
regression analyses, and results showed that the total R-AMSTAR scores and PRISMA scores were 
statistically significantly associated with funding sources in either bivariate or multiple variable linear 
regression analyses. However, funding source was the variable that contributed to quality scores. 
Finally, we were mainly concerned about the registration status of systematic reviews in this study, and 
further studies are needed to explore other strategies for improving the quality of systematic reviews, 
such as the impact of funding sources. 
In conclusions, prospective registration could be a strategy to improve the overall methodological 
quality of systematic reviews, although its impact on the overall reporting quality was not significant.  
Further studies are required to investigate causes of the observed association of prospective registration 
of protocols and the methodological quality of published systematic reviews. 
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Table 1 The characteristics of systematic review included systematic reviews  
 
Characteristics 
Registered (n=100) 
Non-registered 
(n=50) 
P value  
(Registered vs. 
non-registered) 
 
Non-Cochrane 
(n=50) 
Cochrane 
(n=50) 
Category of journals: %     
- General 29 (58.0) 0 (0.0) 23 (46.0) 0.04 
- Specialty 21 (42.0) 50 (100.0) 27 (54.0) 0.04 
Indexed in SCI journals: % 47 (94.0) 50 (100.0) 44 (88.0) 0.04 
Journal impact factor:  
    median (IQR) 
3.057 (2.562, 5.722) 6.103 
2.448 (1.776, 
3.489) 
<0.001 
No. of authors: median (IQR) 5 (4, 7.75) 4 (3,5.75) 5 (4, 7) 1.00 
No. of RCTs included: median (IQR) 11 (7.75, 17.5) 8 (3.25, 20) 9 (5.57, 14.25) 0.73 
No. of patients included: median (IQR) 1549 (801.25, 3567) 1265 (477, 3579) 
956 (465.25, 
2009.25) 
0.07 
Funding sources: %     
- Non-profit sponsor 27 (54.0) 41 (82.0) 13 (26.0) <0.001 
- For-profit sponsor 1 (2.0) 0 (0.0) 0 (0.0) 0.80 
- None 14 (28.0) 2 (4.0) 11 (22.0) 0.37 
- Unclear 3 (6.0) 0 (0.0) 8 (16.0) 0.01 
- Not reported 5 (10.0) 7 (14.0) 18 (36.0) <0.001 
The name of the registers: %     
-PROSPERO 44 (88.0) 0 (0.0) 0 (0.0) 0.002 
-Cochrane 0 (0.0) 50 (100.0) 0 (0.0) 0.001 
-Others 6 (12.0) 0 (0.0) 0 (0.0) 0.19 
Is published protocol available? (Yes) % 8 (16.0) 50 (100.0) 0 (0.0) <0.001 
Category of interventions: %     
- Pharmacological 10 (20.0) 18 (36.0) 7 (14.0) 0.06 
- Non-pharmacological 36 (72.0) 32 (64.0) 37 (74.0) 0.45 
- Both 4 (8.0) 0 (0.0) 6 (12.0) 0.08 
Note: SCI, Science Citation Index; IQR, interquartile range; NA, not application 
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Figure 1. 
The flow diagram of literature selection 
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Figure 2. 
Countries of included systematic reviews (Ordered by number of registered non-Cochrane reviews) 
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Figure 3. 
Categories of disease of included systematic reviews (Ordered by number of registered non-Cochrane 
reviews): Unclear, indicates that included systematic reviews can’t be classified according to ICD-10, 
such as adult critically ill patients; Not applicable, indicates that the topic of included systematic 
reviews doesn’t focus on disease, such as responses to food price changes or adherence to drug 
treatment.
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Figure 4.  
Results of R-AMSTAR score 
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Figure 5.  
Results of PRISMA assessment 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
20 
 
 
Figure 6.  
Results of total PRISMA score 
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• Highlights: 
 
• Key finding: Prospective registration may at least indirectly improve the overall methodological 
quality of systematic reviews. 
 
• What this adds to what is known: We conducted firstly a meta-epidemiological study to 
investigate the impact of prospective registration on reporting and methodological quality of 
systematic reviews. It was significantly meaningful that prospective registration improved the 
methodological quality of systematic reviews. 
 
• What is the implication, what should change now: Many of published systematic reviews were 
poorly conducted and reported. Strategies improving the quality of systematic reviews should be 
explored to reduce this avoidable waste in research. A protocol written in advance of a systematic 
review may reduce bias in the conduct and reporting process, and should be performed in further 
training of authors of systematic reviews. 
